IV mutation literature information.


  Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.
 PMID: 24705721       2014       American journal of physiology. Lung cellular and molecular physiology
Abstract: D325A+R343V and D325S+R343V also strongly inhibited HA activity, and markedly aggregated, the 1968 pandemic H3N2 strain, Aichi68.
Abstract: D325S+R343V significantly reduced viral loads and mortality of mice infected with Aichi68, whereas wild-type SP-D NCRD did not.
Abstract: Importantly, we now show that D325A+R343V and D325S+R343V inhibited Cal09 H1N1 and related strains, and reduced uptake of Cal09 by epithelial cells.


  Molecular mechanisms of inhibition of influenza by surfactant protein D revealed by large-scale molecular dynamics simulation.
 PMID: 24224757       2013       Biochemistry
Abstract: Furthermore, the blocking mechanism of HA differs for WT and D325A+R343V because of alternate glycan binding modes.
Abstract: On the basis of the D325A+R343V-Man9 structure and other crystallographic data, models of complexes between HA and WT or D325A+R343V were produced and subjected to molecular dynamics.
Abstract: Simulations reveal that whereas WT and D325A+R343V both block the sialic acid receptor site of HA, the D325A+R343V complex is more stable, with stronger binding caused by additional hydrogen bonds and hy


  Viral aggregating and opsonizing activity in collectin trimers.
 PMID: 19837850       2010       American journal of physiology. Lung cellular and molecular physiology
Abstract: The most effective substitution involved replacement of arginine 343 with valine (hSP-D-NCRD/R343V).
Abstract: These effects were further increased by cross-linking of hSP-D-NCRD/R343V trimers with MAbs directed against areas of the hSP-D-NCRD not involved in viral binding.
Abstract: Unlike the wild-type human SP-D hSP-D-NCRD, hSP-D-NCRD/R343V also induced viral aggregation.


  Increasing antiviral activity of surfactant protein d trimers by introducing residues from bovine serum collectins: dissociation of mannan-binding and antiviral activity.
 PMID: 20591072       2010       Scandinavian journal of immunology
Abstract: We now show, however, that combined mutants containing the RAK insertion and R343V or R343I substitutions have greatly increased mannan-binding ability, but lower IAV binding or inhibiting activity than mutants containing R343V or R343I substitutions only.
Method: Using the wild type hSP-D-NCRD and R343V mutant we not found evidence of aggregation on storage of the proteins.
Result: All of the serum collectins have a hydrophobic residue at position 343 (SP-D numbering), and we have previously shown that hSP-D-NCRDs with an R343V or R343I substitution have increased mannan binding activity and greatly increased antiviral activity.


  Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343.
 PMID: 19249874       2009       Biochemistry
Abstract: A mutant with valine at 343 (R343V) showed enhanced binding to mannan relative to wild type and R343A.
Abstract: Although hNCRDs show negligible binding to influenza A virus (IAV), R343V showed markedly enhanced viral neutralizing activity.
Abstract: Both proteins showed efficient recognition of linear and branched subdomains of high-mannose glycans on carbohydrate microarrays, and R343V showed increased binding to a subset of the oligosaccharides.



Browser Board

 Co-occurred Entities




   Filtrator